Stock data
ADMA Biologics Inc (ADMA)
ADMA Biologics Inc (ADMA) reported revenue of US$510.17M and net income of US$146.93M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$510.17M | US$292.76M | US$191.44M | US$146.93M | — |
| 2024 | US$426.45M | US$219.55M | US$138.98M | US$197.67M | — |
| 2023 | US$258.21M | US$88.94M | US$21.63M | -US$28.24M | — |
| 2022 | US$154.08M | US$35.27M | -US$39.37M | -US$65.90M | — |
| 2021 | US$80.94M | US$1.17M | -US$58.37M | -US$71.65M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$124.39M | US$37.82M | — |
| 2026-03-31 | US$114.49M | US$45.33M | — |
| 2025-12-31 | US$139.16M | US$49.38M | — |
| 2025-09-30 | US$134.22M | US$36.43M | — |
| 2025-06-30 | US$121.98M | US$34.22M | — |
| 2025-03-31 | US$114.80M | US$26.90M | — |
| 2024-12-31 | US$117.55M | US$111.90M | — |
| 2024-09-30 | US$119.84M | US$35.91M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.